mTOR coordinates growth signals with metabolic pathways and protein synthesis and is hyperactivated in many human cancers. mTOR exists in two complexes: mTORC1, which stimulates protein, lipid, and ribosome biosynthesis, and mTORC2, which regulates cytoskeleton functions. While mTOR is known to be involved in the DNA damage response, little is actually known regarding the functions of mTORC1 compared to mTORC2 in this regard or the respective impacts on transcriptional versus translational regulation. We show that mTORC1 and mTORC2 are both required to enact DNA damage repair and cell survival, resulting in increased cancer cell survival during DNA damage. Together mTORC1 and -2 enact coordinated transcription and translation of protective cell cycle and DNA replication, recombination, and repair genes. This coordinated transcriptional-translational response to DNA damage was not impaired by rapalog inhibition of mTORC1 or independent inhibition of mTORC1 or mTORC2 but was blocked by inhibition of mTORC1/2. Only mTORC1/2 inhibition reversed cancer cell resistance to DNA damage and replicative stress and increased tumor cell killing and tumor control by DNA damage therapies in animal models. When combined with DNA damage, inhibition of mTORC1/2 blocked transcriptional induction more strongly than translation of DNA replication, survival, and DNA damage response mRNAs.KEYWORDS breast cancer, DNA damage, mTOR, protein synthesis, translational control, DNA damage response, protein synthesis, transcriptional control T he mammalian target of rapamycin (mTOR) is a downstream kinase of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway that integrates signals from growth factors and nutrients to regulate key metabolic and macromolecular processes and is dysregulated in many human cancers (1-3). mTOR exists in two complexes, mTOR complex 1 (mTORC1) and mTORC2, which mediate different functions defined by their molecular composition. In response to nutrient levels, growth factors, and other mitogenic signals, mTORC1 regulates protein synthesis, lipid synthesis, and ribosome biogenesis (1, 3). mTORC1 includes the proteins mTOR, Raptor, and GL, among others (4), and is responsible for the phosphorylation (inactivation) of the negative regulator of cap binding protein eukaryotic translation initiation factor 4E (eIF4E) known as 4E-BP1. 4E-BP1 binds and blocks the activity of the translation initiation factor eIF4E by competing for interaction with translation initiation factor eIF4G, a molecular scaffold upon which the 40S ribosome and translation factors assemble (5). mTORC2 includes the proteins mTOR, Rictor, and GL, among others. mTORC2 regulates cytoskeleton